As of 3:59pm ET
| -0.006 / -1.33%|
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +913.51% increase from the last price of 0.44.
The current consensus among 1 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.